Preclinical Studies on Intestinal Administration of Antisense Oligonucleotides as a Model for Oral Delivery for Treatment of Duchenne Muscular Dystrophy

Author(s):
Putten, M. van; Young, C.; Berg, S. van den; Pronk, A.; Hulsker, M.; Karnaoukh, T.G.; Vermue, R.; Dijk, K.W. van; Kimpe, S. de; Aartsma-Rus, A.
Published
2014
Publication type
Article / Letter to editor
antisense oligonucleotidesbioavailabilityDuchenne muscular dystrophydystrophinoral administration
Date issued
2014-11-30
Language
English
Is part of
Molecular Therapy - Nucleic Acids
hdl
1887/105793
doi
10.1038/mtna.2014.62